CA2355251A1 - New .beta.-amide and .beta.-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists - Google Patents
New .beta.-amide and .beta.-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists Download PDFInfo
- Publication number
- CA2355251A1 CA2355251A1 CA002355251A CA2355251A CA2355251A1 CA 2355251 A1 CA2355251 A1 CA 2355251A1 CA 002355251 A CA002355251 A CA 002355251A CA 2355251 A CA2355251 A CA 2355251A CA 2355251 A1 CA2355251 A1 CA 2355251A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- diphenylpropionic acid
- methyl
- methoxy
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/22—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to two ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19858779A DE19858779A1 (de) | 1998-12-18 | 1998-12-18 | Neue ß-Amido und ß-Sulfonamidocarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
DE19858779.1 | 1998-12-18 | ||
PCT/EP1999/009679 WO2000037450A1 (de) | 1998-12-18 | 1999-12-09 | NEUE β-AMIDO- UND β-SULFONAMIDOCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELIN-REZEPTORANTAGONISTEN |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2355251A1 true CA2355251A1 (en) | 2000-06-29 |
Family
ID=7891778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002355251A Abandoned CA2355251A1 (en) | 1998-12-18 | 1999-12-09 | New .beta.-amide and .beta.-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1140867A1 (pt) |
JP (1) | JP2002533330A (pt) |
KR (1) | KR20010101279A (pt) |
CN (1) | CN1334806A (pt) |
AR (1) | AR023353A1 (pt) |
AU (1) | AU3036400A (pt) |
BG (1) | BG105618A (pt) |
BR (1) | BR9916331A (pt) |
CA (1) | CA2355251A1 (pt) |
CZ (1) | CZ20012186A3 (pt) |
DE (1) | DE19858779A1 (pt) |
HK (1) | HK1042095A1 (pt) |
HU (1) | HUP0201321A3 (pt) |
IL (1) | IL143451A0 (pt) |
NO (1) | NO20013000L (pt) |
SK (1) | SK8682001A3 (pt) |
TR (1) | TR200101780T2 (pt) |
WO (1) | WO2000037450A1 (pt) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8304403B2 (en) | 2005-11-23 | 2012-11-06 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0301892A3 (en) * | 2000-11-17 | 2005-06-28 | Warner Lambert Company Llc Mor | Pharmaceutical compositions for treatment of sexual dysfunction and their preparation |
EP2712865B1 (en) * | 2009-07-10 | 2016-03-16 | Cadila Healthcare Limited | Improved process for the preparation of ambrisentan |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8912700D0 (en) * | 1989-06-02 | 1989-07-19 | Shell Int Research | Herbicidal compounds |
DE4329911A1 (de) * | 1993-09-04 | 1995-03-09 | Basf Ag | Substituierte Milchsäurederivate mit einem N-organischen Rest in beta-Position |
TR199901416T2 (xx) * | 1996-12-18 | 1999-08-23 | Basf Aktiengesellschaft | Heterosiklik karbonikasit t�revleri. |
DE19726146A1 (de) * | 1997-06-19 | 1998-12-24 | Basf Ag | Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
-
1998
- 1998-12-18 DE DE19858779A patent/DE19858779A1/de not_active Withdrawn
-
1999
- 1999-12-09 CA CA002355251A patent/CA2355251A1/en not_active Abandoned
- 1999-12-09 BR BR9916331-4A patent/BR9916331A/pt not_active Application Discontinuation
- 1999-12-09 KR KR1020017007615A patent/KR20010101279A/ko not_active Application Discontinuation
- 1999-12-09 TR TR2001/01780T patent/TR200101780T2/xx unknown
- 1999-12-09 CN CN99814580A patent/CN1334806A/zh active Pending
- 1999-12-09 JP JP2000589522A patent/JP2002533330A/ja active Pending
- 1999-12-09 EP EP99964533A patent/EP1140867A1/de not_active Withdrawn
- 1999-12-09 AU AU30364/00A patent/AU3036400A/en not_active Abandoned
- 1999-12-09 IL IL14345199A patent/IL143451A0/xx unknown
- 1999-12-09 WO PCT/EP1999/009679 patent/WO2000037450A1/de not_active Application Discontinuation
- 1999-12-09 SK SK868-2001A patent/SK8682001A3/sk unknown
- 1999-12-09 HU HU0201321A patent/HUP0201321A3/hu unknown
- 1999-12-09 CZ CZ20012186A patent/CZ20012186A3/cs unknown
- 1999-12-17 AR ARP990106523A patent/AR023353A1/es unknown
-
2001
- 2001-06-15 NO NO20013000A patent/NO20013000L/no not_active Application Discontinuation
- 2001-06-18 BG BG105618A patent/BG105618A/xx unknown
-
2002
- 2002-05-31 HK HK02104116.9A patent/HK1042095A1/zh unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8304403B2 (en) | 2005-11-23 | 2012-11-06 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US8642576B2 (en) | 2005-11-23 | 2014-02-04 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
Also Published As
Publication number | Publication date |
---|---|
DE19858779A1 (de) | 2000-06-21 |
HUP0201321A3 (en) | 2003-02-28 |
IL143451A0 (en) | 2002-04-21 |
JP2002533330A (ja) | 2002-10-08 |
BG105618A (en) | 2002-01-31 |
NO20013000L (no) | 2001-08-15 |
WO2000037450A1 (de) | 2000-06-29 |
HUP0201321A2 (hu) | 2002-12-28 |
AU3036400A (en) | 2000-07-12 |
EP1140867A1 (de) | 2001-10-10 |
SK8682001A3 (en) | 2002-08-06 |
TR200101780T2 (tr) | 2001-11-21 |
CZ20012186A3 (cs) | 2002-07-17 |
BR9916331A (pt) | 2001-09-11 |
HK1042095A1 (zh) | 2002-08-02 |
AR023353A1 (es) | 2002-09-04 |
CN1334806A (zh) | 2002-02-06 |
NO20013000D0 (no) | 2001-06-15 |
KR20010101279A (ko) | 2001-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CZ113297A3 (cs) | Derivát karboxylové kyseliny | |
NO311571B1 (no) | Nye karboksylsyre-derivater og deres anvendelse | |
US2624731A (en) | S-phenylpyrimidkn e x derivativesx | |
CA2307770A1 (en) | Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists | |
CA2355251A1 (en) | New .beta.-amide and .beta.-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists | |
CA2294050A1 (en) | New .beta.-amino and .beta.-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists | |
KR20000057642A (ko) | 헤테로시클릭 카르복실산 유도체, 그의 제제 및 엔도텔린 수용체길항제로서의 용도 | |
CA2302350A1 (en) | Novel carboxylic acid derivatives, their production and their use as mixed eta/etb endothelin-receptor antagonists | |
NO310651B1 (no) | Karboksylsyrederivater | |
CA2379545A1 (en) | Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists | |
CA2321182A1 (en) | 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists | |
CA2375666A1 (en) | Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists | |
EP1037883A1 (de) | NEUE HETEROCYCLISCH SUBSTITUIERTE $g(a)-HYDROXYCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELINREZEPTORANTAGONISTEN | |
JP2002505324A (ja) | 不斉に置換された新規のカルボン酸誘導体、その製造方法ならびに混合eta/etb受容体アンタゴニストとしての使用 | |
MXPA99011504A (es) | Novedosos derivados de acido beta-amino y beta-azido carboxilicos, su preparacion y uso como antagonistas receptores de endotelina | |
CA2340167A1 (en) | New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists | |
CA2410304A1 (en) | Novel carbamates and ureas production and use thereof as endothelin receptor antagonists | |
MXPA00007417A (en) | Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta | |
MXPA00006463A (en) | 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists | |
DE19652763A1 (de) | Heterozyklische Carbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |